A provision of the Indian Patents Act allows for a compulsory license to be awarded after three years of the grant of patent on drugs that are deemed to be too costly. Other patent rulings are imminent. A long-running case...
Keywords: German drug maker Bayer, Bayer's monopoly, HIV/AIDS drugs, cancer drug Glivec
Read More